NMRA

Neumora Therapeutics, Inc. $0.37 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.5%
Next 1 month
+1.2%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 20
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.58%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.47 +1.2%
$798228/day volume 126% volatility -85% 1-year
52-week range · 2% of the way up · -90% from the high
$0.31$3.65

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 5 days) · EPS est. -0.19.

1-day std dev
8.5%
Finished up
42%
Biggest pop
+4.9%
Biggest drop
-17.2%

Standard deviation of the close-to-close move over the last 12 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-14 beat -0.24 -0.23 +5.3% -2.3% -7.5% -5.8%
2026-05-07 beat -0.31 -0.30 +3.2% +0.0% -16.7% -15.5%
2026-03-30 miss -0.33 -0.35 -7.0% -7.7% -17.2% -8.6%
2025-11-06 miss -0.34 -0.35 -4.3% -8.8% -1.5% +2.7%
2025-08-06 beat -0.37 -0.33 +10.4% +4.4% +3.8% -0.6%
2025-05-12 miss -0.38 -0.42 -10.0% -0.3% -2.0% +5.3%
2025-03-03 beat -0.44 -0.37 +16.3% +2.6% -9.9% -14.1%
2024-11-12 miss -0.38 -0.45 -18.3% -4.5% -17.1% -27.7%
2024-08-06 miss -0.36 -0.37 -3.5% -0.5% +0.3% -5.5%
2024-05-07 miss -0.32 -0.34 -6.8% +0.0% +4.9% +2.5%
2024-03-07 miss -0.60 -0.71 -18.3% +2.5% +3.3% -17.8%
2023-11-01 miss -0.43 -1.14 -164.1% -0.4% +1.2% -1.8%

Not investment advice.